Bruker AXS Launches New High-Throughput Screening System for Combinatorial Analysis.Business Editors, Science/Medical Writers MADISON, Wis.--(BUSINESS WIRE)--Aug. 2, 2002 Bruker AXS Bruker AXS is an international instrument manufacturer and supplier. The company is part of Bruker and specialized on Analytical X-Ray Systems. The main parts are the X-Ray diffraction and the X-Ray spectrometry. Inc. (Nasdaq:BAXS), announced a new product for use in advanced materials Advanced Materials is a leading peer-reviewed materials science journal published every two weeks. Advanced Materials includes Communications, Reviews, and Feature Articles from the cutting edge of materials science, including topics in chemistry, physics, science and research at the 51st Denver X-Ray Conference. The D8 DISCOVER CST CST abbr. 1. Central Standard Time 2. convulsive shock treatment CST Central Standard Time Noun 1. (comprised of a D8 DISCOVER with GADDS GADDS Geophysical Archive Data Delivery System (Australia) GADDS General Area Detector Diffraction System (X-ray) for combinatorial screening in transmission) is a high-throughput X-ray analysis tool specifically targeted at pharmaceutical and combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. applications, a high growth area in the analysis of advanced materials, including drug development. The D8 DISCOVER CST was designed in response to customer demand for more efficient ways of analyzing many samples at high speed. Based on the well-proven D8 platform and the GADDS software technology, the new system provides a highly automated, easy to operate solution for the combinatorial screening and analysis market, accomplishing high sample throughput while greatly improving data quality. The D8 DISCOVER CST represents an ideal expansion of the Bruker AXS product portfolio for high-throughput solutions in combinatorial and phase mapping applications. "I am very pleased with the speed in which Bruker AXS has provided a well timed Adj. 1. well timed - done or happening at the appropriate or proper time; "a timely warning"; "with timely treatment the patient has a good chance of recovery"; "a seasonable time for discussion"; "the book's publication was well timed" and targeted response to a growing market that continuously requires more advanced and efficient tools for high-throughput analysis," commented Steven M. Pomerantz, Vice President of Sales & Marketing for Bruker AXS. About Bruker AXS Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. The company develops, manufactures and markets worldwide advanced X-ray solutions for the three-dimensional structure determination of biological and chemical compounds, as well as for advanced materials research and analysis. Its diverse customer base includes pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , advanced materials, semiconductor, synthetic polymer Synthetic polymers are often referred to as "plastics", such as the well-known polyethylene and nylon. However, most of them can be classified in at least three main categories: thermoplastics, thermosets and elastomers. , and basic materials companies, as well as university and government research customers. Applications include x-ray crystallography X-ray crystallography, the study of crystal structures through X-ray diffraction techniques. When an X-ray beam bombards a crystalline lattice in a given orientation, the beam is scattered in a definite manner characterized by the atomic structure of the lattice. for structural proteomics, and automated systems for combinatorial materials sciences. Bruker AXS has the most diverse set of x-ray technology platforms for molecular and materials analysis. Safe-Harbor Statement Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a high degree of risk and uncertainty that exist in the Company's operations and business environment. Such statements are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could affect actual events or results include risks associated with performance under the Company's agreements with third parties, research and development progress, competitive products and the strength of the Company's patent portfolio. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion